Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chavant Capital Acquisition Corp (CLAY)

Chavant Capital Acquisition Corp (CLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,623
  • Shares Outstanding, K 2,779
  • Annual Sales, $ 0 K
  • Annual Income, $ -780 K
  • 60-Month Beta 0.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLAY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.28 +28.74%
on 12/15/23
12.50 -14.72%
on 12/14/23
-0.55 (-4.91%)
since 11/21/23
3-Month
8.28 +28.74%
on 12/15/23
12.50 -14.72%
on 12/14/23
-0.39 (-3.53%)
since 09/21/23
52-Week
8.28 +28.74%
on 12/15/23
12.50 -14.72%
on 12/14/23
+0.43 (+4.20%)
since 12/21/22

Most Recent Stories

More News
LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member...

CLAY : 10.66 (+6.39%)
SES : 1.2900 (+12.17%)
AVXL : 3.68 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Chavant Capital Acquisition Corp. entered into a business combination agreement with Mobix Labs.

See More

Key Turning Points

3rd Resistance Point 14.53
2nd Resistance Point 13.27
1st Resistance Point 11.96
Last Price 10.66
1st Support Level 9.39
2nd Support Level 8.13
3rd Support Level 6.82

See More

52-Week High 12.50
Fibonacci 61.8% 10.89
Last Price 10.66
Fibonacci 50% 10.39
Fibonacci 38.2% 9.89
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar